Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.
Level 4 - case-series / case-control
Mouse QTL and functional assays combined with a human observational cohort genetic association study
PubMed 20688780 · doi:10.1101/gr.104976.110
What was done
Researchers mapped a neuropathic pain-related quantitative trait locus (Pain1) in mice using recombinant progeny testing and recombinant inbred segregation testing to a 4.2-Mb interval on chromosome 15 containing 155 genes. Whole-genome microarray expression profiling and bioinformatics were applied to prioritize candidate genes, identifying Cacng2 (stargazin). Electrophysiological and behavioral phenotypes were evaluated in hypomorphic stargazer mice. Polymorphisms in human CACNG2 were then tested for association with chronic pain in a cohort of cancer patients who underwent breast surgery.
What was found
The Pain1 QTL was localized to a 4.2-Mb interval on mouse chromosome 15. Functional assays in hypomorphic stargazer mice demonstrated electrophysiological and behavioral differences in pain processing. Human CACNG2 polymorphisms were associated with chronic pain following breast surgery. The abstract reports no numerical values, effect sizes, or p-values.
Why it matters
The study identifies CACNG2 (encoding stargazin, involved in AMPA receptor trafficking and calcium channel function) as a cross-species genetic factor influencing susceptibility to chronic neuropathic pain after nerve injury.
Limits
No sample sizes, statistical values, or effect estimates are reported in the abstract. The clinical association is restricted to a single observational cohort of post-surgical breast cancer patients, limiting generalizability to other forms of neuropathic pain. Unmeasured clinical and psychosocial confounders cannot be evaluated from the abstract alone.
Cited by
- supports Genetic variants in glutamate signaling pathways are linked to chronic pain.